Example: Heart Attack

Search clinical trials for: Acetylcysteine

Total 451 results

    • NCT02865629
      Unknown status
      N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring
      Conditions: Depression
    • NCT04419025
      Recruiting
      Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
      Conditions: COVID; Sars-CoV2; SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere; Oxidative Stress
    • NCT02788292
      Unknown status
      Effect of N-Acetylcysteine on Autologous Fat Graft Survival
      Conditions: Adipose Tissue Atrophy; Deformity of Reconstructed Breast; Graft Loss
    • NCT02252341
      Unknown status
      Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder
      Conditions: Bipolar Disorder
    • NCT02124525
      Unknown status
      N-acetylcysteine for Tobacco Smoking
      Conditions: Tobacco Smoking; Oxidative Stress; Inflammation
    • NCT01808521
      Completed
      A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
      Conditions: Purpura, Thrombotic Thrombocytopenic; TTP
    • NCT01403506
      Unknown status
      Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
      Conditions: Disorder Related to Renal Transplantation
    • NCT01501110
      Completed
      Effects of N-acetylcysteine on Low T3 Syndrome
      Conditions: Acute Myocardial Infarction; Euthyroid Sick Syndrome; Ischemic Heart Disease
    • NCT03197103
      Unknown status
      The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction
      Conditions: Breast; Deformity, Congenital; Graft Loss; Adipose Tissue Atrophy; Breast; Atrophy
    • NCT02505477
      Recruiting
      Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
      Conditions: Schizophrenia; Cognitive Deficits; Schizophrenia; Negative Type
    • NCT00998972
      Completed
      N-acetyl-cysteine (NAC) and Kidney Graft Function
      Conditions: Brain Death; Chronic Renal Insufficiency
    • NCT00967005
      Completed
      N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
      Conditions: Gambling; Tobacco Use Disorder
    • NCT03956888
      Not yet recruiting
      The Anti-oxidant Effects of N-Acetylcysteine in Chronic Obstructive Pulmonary Disease (COPD)
      Conditions: Chronic Obstructive Pulmonary Disease
    • NCT04481035
      Active, not recruiting
      Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
      Conditions: Neurofibromatosis 1
    • NCT04278898
      Not yet recruiting
      Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine
      Conditions: Autism Spectrum Disorder
    • NCT00676195
      Completed
      An Open-Label Study of N-Acetyl Cysteine in Children With Autism
      Conditions: Autistic Disorder
    • NCT02212678
      Completed
      Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease
      Conditions: Parkinson Disease
    • NCT01359722
      Unknown status
      N-acetylcysteine to Prevent Renal Failure
      Conditions: Kidney Failure, Acute; Oxidative Stress Induction
    • NCT00532688
      Unknown status
      N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
      Conditions: Heart Failure, Congestive; Kidney Failure, Chronic
    • NCT04123405
      Recruiting
      Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis
      Conditions: Rhinosinusitis
    • NCT04023266
      Recruiting
      A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI
      Conditions: STEMI
    • NCT00994305
      Unknown status
      Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal Transplant
      Conditions: Renal Transplantation
    • NCT04368598
      Recruiting
      The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP
      Conditions: Immune Thrombocytopenia
    • NCT01849016
      Completed
      N-Acetylcysteine in Patients With Sickle Cell Disease
      Conditions: Sickle Cell Disease
    • NCT03707951
      Recruiting
      N-Acetylcysteine for Adolescent Alcohol Use Disorder
      Conditions: Alcohol Use Disorder
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations